Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02001714 · ClinicalTrials.gov registry record · NA
Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms
A NA study, sponsored by Ananias Diokno.
- Completed
- Registry status
- NA
- Development phase
- 463
- Enrollment target
NCT02001714: Completed NA study, sponsored by Ananias Diokno.
NCT02001714 is a NA study that has completed, run by Ananias Diokno. The registered enrollment target is 463 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02001714, a NA study, has completed, sponsored by Ananias Diokno.
- COMPLETED
- Registry status
- NA
- Development phase
- 463 participants
- Enrollment target
Study Summary
This three-site randomized controlled trial compares the effectiveness and cost-effectiveness of a group-administered behavioral treatment program to no treatment. Women with stress, urgency, or mixed urinary incontinence will be recruited and screened centrally, evaluated clinically at each of three study sites, and random assigned to one of two treatment arms: 1. Group behavioral treatment or 2. No treatment. Group treatment modalities have the potential to reach a larger population of older women with urinary incontinence, not only in the traditional medical settings, but also in community settings. The investigators hypothesize that group behavioral treatment will be more effective than no treatment. The investigators hypothesize that the group treatment will be cost-effective compared to no treatment.
Primary Outcome
The primary outcome is the self-reported urinary incontinence severity as measured by the International Consultation on Incontinence questionnaire-short form (ICI-Q). This short and simple questionnaire is used to screen for incontinence (urine leakage) to obtain a brief yet comprehensive summary of the level, impact and perceived cause of symptoms of incontinence. The ICI-Q consists of four questions and numeric scales: 1. How much do you leak urine? (0-5); never - all the time, 2. How much uri
Interventions
- BEHAVIORAL Group Behavioral Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 463 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT02001714 record still lists
NCT02001714 is an interventional study that assigns participants to a tested intervention. The registered 463 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 1 intervention - of which Group Behavioral Treatment is the first listed.
NCT02001714 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02001714 about?
NCT02001714 is a clinical study titled "Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms". This three-site randomized controlled trial compares the effectiveness and cost-effectiveness of a group-administered behavioral treatment program to no treatment. Women with stress, urgency, or mixed urinary incontinence will be recruited and screened centrally, evaluated clinically at each of thre...
What is the current status of trial NCT02001714?
This trial is currently completed. It is a NA study. The enrollment target is 463 participants. The study started on 2013-09. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02001714?
The interventions under investigation include: Group Behavioral Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02001714?
This trial is sponsored by Ananias Diokno, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02001714's enrollment target sits among peer trials
463 222nd of 2000 higher than 1,779 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04787744 · 464 participants · Phase 2
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- NCT04855656 · 464 participants · Phase 1
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
- NCT06283927 · 464 participants
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- NCT06444295 · 464 participants · NA
Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia